<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To review evidence for a relationship between dermal neurovascular dysfunction and other components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We review and present data supporting concepts relating dermal neurovascular function to <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Skin blood flow can be easily measured by laser Doppler techniques </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Heat and gravity have been shown to have specific neural, nitrergic, and independent mediators to regulate skin blood flow </plain></SENT>
<SENT sid="4" pm="."><plain>We describe data showing that this new tool identifies dermal neurovascular dysfunction in the majority of type 2 diabetic patients </plain></SENT>
<SENT sid="5" pm="."><plain>The defect in skin vasodilation is detectable before the development of <z:mp ids='MP_0002055'>diabetes</z:mp> and is partially correctable with <z:chebi fb="0" ids="50864">insulin sensitizers</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>This defect is associated with C-fiber dysfunction (i.e., the dermal neurovascular unit) and coexists with variables of the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome </plain></SENT>
<SENT sid="7" pm="."><plain>The defect most likely results from an imbalance among the endogenous <z:chebi fb="1" ids="35620">vasodilator</z:chebi> compound nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>, the <z:chebi fb="1" ids="35620">vasodilator</z:chebi> neuropeptides substance P and calcitonin gene-related <z:chebi fb="7" ids="16670">peptide</z:chebi>, and the vasoconstrictors <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> and endothelin </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> per se increases skin vasodilation and does not impair the responses to gravity, which is opposite to that of <z:mp ids='MP_0002055'>diabetes</z:mp>, suggesting that the effects of <z:mp ids='MP_0002055'>diabetes</z:mp> override and counteract those of <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These observations suggest that dermal neurovascular function is largely regulated by peripheral C-fiber neurons and that dysregulation may be a component of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>